Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Change in Cash (2023 - 2025)

Historic Change in Cash for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $553041.0.

  • Onconetix's Change in Cash rose 19388.76% to $553041.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $495061.0, marking a year-over-year increase of 10677.01%. This contributed to the annual value of -$3.9 million for FY2024, which is 8156.54% up from last year.
  • Latest data reveals that Onconetix reported Change in Cash of $553041.0 as of Q3 2025, which was up 19388.76% from -$1.3 million recorded in Q2 2025.
  • Onconetix's 5-year Change in Cash high stood at $930693.0 for Q1 2025, and its period low was -$12.0 million during Q2 2023.
  • Moreover, its 3-year median value for Change in Cash was -$1.3 million (2025), whereas its average is -$2.3 million.
  • Per our database at Business Quant, Onconetix's Change in Cash soared by 6244.94% in 2024 and then soared by 112878.79% in 2025.
  • Over the past 3 years, Onconetix's Change in Cash (Quarter) stood at -$3.1 million in 2023, then skyrocketed by 109.84% to $305005.0 in 2024, then surged by 81.32% to $553041.0 in 2025.
  • Its Change in Cash stands at $553041.0 for Q3 2025, versus -$1.3 million for Q2 2025 and $930693.0 for Q1 2025.